Nasus Pharma Ltd. (NSRX)

Nasus Pharma Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	-10.55	-5.86	-1.53	-1.05	-1.71
Loss (Gain) From Sale of Investments	0.63	0.95	0.44	-0.22	0.09
Stock-Based Compensation	0.81	0.45	0.01	0.04	0.02
Other Operating Activities	-0.06	0.01	0.01	0.08	-0.41
Change in Accounts Payable	-0.34	0.15	-0.01	-0.12	0.15
Change in Other Net Operating Assets	-0.91	-0.57	0.41	0.28	0.33
Operating Cash Flow	-10.52	-4.92	-0.67	-1.03	-1.21
Operating Cash Flow Growth	-	-	-	-	-

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Capital Expenditures	-0.02	-0.01	-	-	-
Investment in Securities	-3.95	-3	-	-	-
Other Investing Activities	-	-	-	-	-0.16
Investing Cash Flow	-3.97	-3.01	-	-	-0.16

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Short-Term Debt Issued	-	-	-	0.06	0.5
Total Debt Issued	-	-	-	0.06	0.5
Net Debt Issued (Repaid)	-	-	-	0.06	0.5
Issuance of Common Stock	22.14	8.92	1	1	0.97
Other Financing Activities	0.02	-	-0.23	-	-0.23
Financing Cash Flow	22.16	8.92	0.77	1.06	1.24

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Foreign Exchange Rate Adjustments	-	-0.01	-0	0.01	-0.01
Net Cash Flow	7.67	0.98	0.1	0.04	-0.14

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Free Cash Flow	-10.54	-4.93	-0.67	-1.03	-1.21
Free Cash Flow Growth	-	-	-	-	-
Free Cash Flow Per Share	-1.07	-0.62	-0.10	-0.15	-0.18
Levered Free Cash Flow	-6.98	-3.04	-0.26	-0.54	-
Unlevered Free Cash Flow	-6.98	-3.04	-0.24	-0.51	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Change in Working Capital	-1.25	-0.42	0.41	0.17	0.48

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Mar 25, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 22, 2026

Data Sources Report a data error